A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension:

Anna R. Hemnes, MD Luke G. Silverman-Lloyd, BS Shi Huang, PhD Grant MacKinnon, BS Jeffrey Annis, PhD Carolyn S. Whitmore, MSW Ravinder Mallugari, MBBS Rashundra N. Oggs, NP Rezzan Hekmat, BS Rongzi Shan, MD Pauline P. Huynh, BA Chang Yu, PhD Seth S. Martin, MD, MHS Michael J. Blaha, MD, MPH Evan L. Brittain, MD

16 April, 2021

NZ Respiratory Research Review Issue 190

Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients:

Jennifer A. Bartell, Lea M. Sommer, Rasmus L. Marvig, Marianne Skov, Tacjana Pressler, Søren Molin, Helle Krogh Johansen

8 April, 2021

NZ Respiratory Research Review Issue 191

Sotatercept for the Treatment of Pulmonary Arterial Hypertension:

Marc Humbert, M.D., Ph.D., Vallerie McLaughlin, M.D., J. Simon R. Gibbs, M.D., Mardi Gomberg-Maitland, M.D., Marius M. Hoeper, M.D., Ioana R. Preston, M.D., Rogerio Souza, M.D., Ph.D., Aaron Waxman, M.D., Ph.D., Pilar Escribano Subias, M.D., Ph.D., Jeremy Feldman, M.D., Gisela Meyer, M.D., David Montani, M.D., Ph.D., et al., for the PULSAR Trial Investigators

1 April, 2021

NZ Respiratory Research Review Issue 190

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial:

Prof Marius M Hoeper, MD Prof Hikmet Al-Hiti, MD Prof Raymond L Benza, MD Prof Sung-A Chang, MD Prof Paul A Corris, MD J Simon R Gibbs, MD et al.

24 March, 2021

NZ Respiratory Research Review Issue 190

Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study:

Gudula J A M Boon, Yvonne M Ende-Verhaar, Roisin Bavalia, Lahassan H El Bouazzaoui, Marion Delcroix, Olga Dzikowska-Diduch, Menno V Huisman, Katarzyna Kurnicka, Albert T A Mairuhu, Saskia Middeldorp, Piotr Pruszczyk, Dieuwertje Ruigrok, Peter Verhamme, Hubert W Vliegen, Anton Vonk Noordegraaf, Joris W J Vriend, Frederikus A Klok

23 March, 2021

NZ Respiratory Research Review Issue 190

Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs:

Agathe Jouet, Cyril Gaudin, Nelly Badalato, Caroline Allix-Béguec, Stéphanie Duthoy, Alice Ferré, Maren Diels, Yannick Laurent, Sandy Contreras, Silke Feuerriegel, Stefan Niemann, Emmanuel André, Michel K. Kaswa, Elisa Tagliani, Andrea Cabibbe, Vanessa Mathys, Daniela Cirillo, Bouke C. de Jong, Leen Rigouts, Philip Supply

18 March, 2021

NZ Respiratory Research Review Issue 187

The Use of Intrapleural Thrombolytic or Fibrinolytic Therapy, or Both, via Indwelling Tunneled Pleural Catheters With or Without Concurrent Anticoagulation Use:

Christopher R. Gilbert, DO, FCCP; Candice L. Wilshire, MD; Shu-Ching Chang, PhD; and Jed A. Gorden, MD, FCCP

18 March, 2021

NZ Respiratory Research Review Issue 196

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial:

Prof Robert S Wallis, MD Sibuse Ginindza, MS Trevor Beattie, MSc Nishanee Arjun, BSc Morongwe Likoti, BS Vinodh A Edward, DTech et al.

16 March, 2021

NZ Respiratory Research Review Issue 199

Diagnosis of pleural empyema/parapneumonic effusion by next-generation sequencing:

Yoshiki Shiraishi, Kirill Kryukov, Katsuyoshi Tomomatsu, Fumio Sakamaki,Shigeaki Inoue, So Nakagawa, Tadashi Imanishi & Koichiro Asano

9 March, 2021

NZ Respiratory Research Review Issue 184

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia The SAFER Randomized Clinical Trial:

Jeffrey M. Pernica, MD; Stuart Harman, MD; April J. Kam, MD; Redjana Carciumaru, MSc; Thuva Vanniyasingam, PhD; Tyrus Crawford, BSocSc; Dale Dalgleish, RN, BHScN; Sarah Khan, MD; Robert S. Slinger, MD; Martha Fulford, MD; Cheryl Main, MD; Marek Smieja, MD, PhD; Lehana Thabane, PhD; Mark Loeb, MD

8 March, 2021

NZ Respiratory Research Review Issue 196